IPO Ready WHO GMP Certified Pharma Company Seeks Investment
About Business
We produce and sell many OTC and Rx only products, tablets, capsules, syrups and more.
Clientele type
Tata 1mg, Cipla, Sun pharma, Castle pharma, Medplus, Apollo Pharmacy, Alkem, Castle Biosciences, and more.
Premises
Own manufacturing plant in Pondicherry and 2 3rd party manufacturing plants with lease
Asking Price Includes
Note: Although the company is raising 40 Crores, interested investors can start with an investment as low as 1 lakh in this debt-free company with a buyback guarantee after 1 year.
Reason
Business expansion, New product Development, clinical trials, More R&D and manufacturing facilities. Increase manpower and increase productÂ
More Details
We take pride in our manufacturing units that have been certified by the World Health Organization (WHO) for Good Manufacturing Practice (GMP). Our ultramodern manufacturing plant is equipped with cutting-edge technology and a fully equipped Quality Assurance & Quality Control Department. Our organization is multifaceted, with a proficient R&D team and state-of-the-art facilities that are at par with international standards. Additionally, our strong distribution network and groundbreaking research have positioned us as one of India’s fastest-growing transnational pharmaceutical organizations. We specialize in high-growth specialty segments such as Urology, Nephrology, Oncology, Gynecology, Nutraceuticals, Antibiotics, and pain management, where we consistently offer innovative products to our customers. The company has no debt or loan, it is completely debt free. The company is IPO ready in 2026.
Keywords
Business Tags
₹10 to ₹200 Cr
Complete Investment Banking Solution in 120 Days
Seamless Fundraising/M&A transactions
Start your growth journey with our 25+ Years of Experienced Professional Team.
Contact IBGrid Team